loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Tox21_202458

    Client Email Product
    Menu

    Tox21_202458

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 223Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20648 / DOSAGE - GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DIAZEPAM(UNII: Q3JTX2Q7TU)
    (DIAZEPAM - UNII:Q3JTX2Q7TU)     		DIAZEPAM20mg in 4 | 2.5mg in 0.5 | 10mg in 2

    Inactive Ingredients

    Ingredient Name
    Bausch Health US, LLC
    Oceanside Pharmaceuticals
    Teva Pharmaceuticals USA, Inc.
    ALCOHOL(3K9958V90M)
    BENZOIC ACID(8SKN0B0MIM)
    BENZYL ALCOHOL(LKG8494WBH)
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
    PROPYLENE GLYCOL(6DC9Q167V3)
    SODIUM BENZOATE(OJ245FE5EU)
    WATER(059QF0KO0R)